BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wietzke-Braun P, Meier V, Neubauer-Saile K, Mihm S, Ramadori G. Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients. World J Gastroenterol 2005; 11(39): 6188-6192 [PMID: 16273648 DOI: 10.3748/wjg.v11.i39.6188]
URL: https://www.wjgnet.com/1007-9327/full/v11/i39/6188.htm
Number Citing Articles
1
Ahmad Amanzada, Armin Goralczyk, Federico Moriconi, Martina Blaschke, Inga-Marie Schaefer, David van Thiel, Sabine Mihm, Giuliano Ramadori. Ultra-Rapid Virological Response, Young Age, Low γ-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-α2a MonotherapyDigestive Diseases and Sciences 2011; 56(11): 3296 doi: 10.1007/s10620-011-1933-2
2
Karen F. Murray, James R. Rodrigue, Regino P. González-Peralta, John Shepherd, Bruce A. Barton, Patricia R. Robuck, Kathleen B. Schwarz. Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infectionClinical Trials 2007; 4(6): 661 doi: 10.1177/1740774507085445